Evonik Industries (FRA:EVK) PT Set at €25.00 by HSBC

HSBC set a €25.00 ($29.07) target price on Evonik Industries (FRA:EVK) in a research report released on Wednesday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

A number of other brokerages have also recently issued reports on EVK. Goldman Sachs Group set a €21.00 ($24.42) price objective on shares of Evonik Industries and gave the stock a sell rating in a report on Tuesday, August 13th. JPMorgan Chase & Co. set a €26.00 ($30.23) price objective on shares of Evonik Industries and gave the stock a neutral rating in a report on Thursday, August 1st. Warburg Research set a €36.00 ($41.86) price objective on shares of Evonik Industries and gave the stock a buy rating in a report on Thursday, August 1st. Baader Bank set a €29.00 ($33.72) price objective on shares of Evonik Industries and gave the stock a buy rating in a report on Monday, August 12th. Finally, Berenberg Bank set a €29.00 ($33.72) target price on shares of Evonik Industries and gave the stock a buy rating in a research report on Tuesday, August 20th. Five equities research analysts have rated the stock with a sell rating, eight have given a hold rating and ten have given a buy rating to the company. The stock currently has a consensus rating of Hold and an average target price of €29.59 ($34.41).

Shares of FRA:EVK opened at €23.01 ($26.76) on Wednesday. Evonik Industries has a 1 year low of €26.78 ($31.14) and a 1 year high of €32.97 ($38.34). The firm has a fifty day moving average price of €22.86 and a 200 day moving average price of €24.86.

About Evonik Industries

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.

Recommended Story: Investing strategies using the yield curve

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.